JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2005, 54(5):201-206

Blockers of β-Adrenergic Receptors - a Group of Chiral Agents Stereoselective Synthesis of β-Blockers

R. Čižmáriková1, J. Valentová1, A. J. Hutt2, S. Sedláková1
1 Farmaceutická fakulta Univerzity Komenského v Bratislave, Katedra chemickej teórie liečiv, SR
2 Department of Pharmacy, King's College London, University of London, UK

Besides chromatographic methods and biocatalyzed reactions, another alternative method of obtaining enantiomeric forms of ß-blockers is stereoselective synthesis. This paper links up with two preceding surveys concerning ß-blockers - groups of chiral agents and presents a survey of the hitherto published enantioselective syntheses of (R)- and (S)-enantiomers of β-blockers. In the group of arylaminoethanols, mainly selective reduction of prochiral ketones in the presence of metallic complexes is used in this type of synthesis. Enantiomerically pure ß-blockers of the aryloxyaminopropanol type are synthesized by means of a reaction of pertinent phenols with different chiral precursors, such as (R) and (S)-chloromethyloxirans, (S)-glycidoltosylate, (S)- or (R)-2,3-O-isopropylideneglyceroltosylate, E-(2S,3S)-3-trimethylsilylglycidol and (S)-3-terc-butyl-5-phenyl-oxazolidine-5-ylmethanol. Many of these chiral semiproducts can be prepared from natural substances, such as D-mannitol and L-ascorbic acid.

Keywords: ß-blockers; stereoselective synthesis; arylaminoethanols; aryloxyaminopropanols; enantioselective reduction; chiral precursors

Received: January 31, 2005; Accepted: June 8, 2005; Published: May 1, 2005  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Čižmáriková R, Valentová J, Hutt AJ, Sedláková S. Blockers of β-Adrenergic Receptors - a Group of Chiral Agents Stereoselective Synthesis of β-Blockers. Čes. slov. farm. 2005;54(5):201-206.
Download citation

References

  1. Čižmáriková, R.: Čes. slov. Farm., 2002; 51, 121.
  2. Čižmáriková, R., Valentová, J., Hutt, A. J.: Čes. slov. Farm., 2004; 53, 9.
  3. Ramachandran, P. V., Gong, B. Q., Brown, H. C.: Chirality, 1995; 7, 103. Go to original source...
  4. Ramachandran, P. V.,Teodorovic, A. V., Brown, H. C.: Tetrahedron., 1993; 49, 1725. Go to original source...
  5. Beardsley, D. A., Fischer, G. B., Goralsky, Ch. T. et al.: Tetrahedron Letters, 1994; 35, 1511. Go to original source...
  6. Srebnik, M., Ramachandran, P. V., Brown, H. C.: J. Org. Chem., 1988; 53, 2916. Go to original source...
  7. Gao, J. X., Zhang, H., Yi, X. D. et al.: Chirality, 2000; 12, 383. Go to original source...
  8. Solladié-Cavallo, A.: Zborník prednášok 3rd Course on chiral Chemistry. Bratislava - Smolenice august, 1998. s. 65.
  9. Jurczak, J., Pikul, S., Bauer, T.: Tetrahedron., 1986; 42, 447. Go to original source...
  10. Kirstead, R. W., Faraone, A., Mennona, F. et al.: J. Med. Chem., 1983; 26, 1561. Go to original source... Go to PubMed...
  11. Paquette, L. A. (ed.): Handbook of reagents for organic synthesis. Chiral reagents for asymetric synthesis John Wiley & Sons England, 2003, s. 258-263.
  12. Baldwin, J. J., Raab, A.W., Mensler, K. et al.: J. Org. Chem., 1978; 43, 4876. Go to original source...
  13. Weinstock, L. M., Mulve, D. M., Tull, R.: J. Org. Chem., 1976; 41, 3121. Go to original source... Go to PubMed...
  14. Jung, E. J., Shaw, T. J.: J. Am. Chem. Soc., 1980; 102, 6304. Go to original source...
  15. Baldwin, J. J., Hirschmann, R., Lumma, et al.: J. Med. Chem., 1977; 20, 1024. Go to original source... Go to PubMed...
  16. Baldwin, J. J., Engelhard, E. L., Hirschmann, R. et al.: J. Med. Chem., 1980; 23, 65. Go to original source... Go to PubMed...
  17. Pinza, M., Pifferi, G.: Farmaco., 1994; 49, 683.
  18. Manoury, P. M., Binet, J. L., Rousseau, J. et al.: J. Med. Chem., 1987; 30, 1003. Go to original source... Go to PubMed...
  19. Miyano, S., Lu, L. D. L., Viti, S. M. et al.: J. Org. Chem., 1985; 50, 4350. Go to original source...
  20. Yamamoto, M., Takayanagi, Y., Nihashi, S.: Chirality, 1995; 7, 572. Go to original source...
  21. Jung, S. H., Linh, P. T., Lim, H. K. et al.: Arch. Pharm. Res., 2000; 23, 226. Go to original source... Go to PubMed...
  22. Seki, T., Takezaki, T., Ohuchi, R. et al.: Chem Pharm. Bull., 1995; 43, 1719. Go to original source... Go to PubMed...
  23. Krause, H. W., Schmidt, U., Foken, H.: Pharmazie, 1992; 47, 838.
  24. Fukazawa, N., Tsuneshi, N., Nakajima, Y.: Jpn. Kokai Tokkyo Koho JP 06 116 253 Chem. Abstr. 121, 205 389x (1994).
  25. Klunder, J. M., Soo, Y. Ko, S.Y., Sharpless K. B.: J. Org. Chem., 1986; 51, 3710. Go to original source...
  26. New Trends in Synthetic Medicinal Chemistry. Weiheim, WILEY-VCH Verlag GmbH, D-69469, 2000, s. 125.
  27. Ecker, G., Noe, C. R., Fleischhacker, W.: Monatshefte für Chemie., 1997; 128, 53. Go to original source...
  28. Katsuki, T.: Tetrahedron Letters, 1984; 25, 2821. Go to original source...
  29. Bäckvall, J. E., Björkman, E. E., Byström, S. E.: Tetrahedron Letters, 1982; 23, 943. Go to original source...
  30. Clementi, W. A., Garvey, T. Q., Clifton, G. D. et al.: Chirality, 1994; 6, 169. Go to original source... Go to PubMed...
  31. Jackman, G. P., Iakovidis, D., Nero, T. L. et al.: Eur. J. Med. Chem., 2002; 37, 731. Go to original source... Go to PubMed...
  32. Fuji, M., Muratake,H., Akiyama, M. et al.: Chem. Pharm. Bull., 1992; 40, 2353. Go to original source...
  33. Danilewicz, J. C., Kemp, J. E. G.: J. Med. Chem., 1973; 16, 168. Go to original source... Go to PubMed...
  34. Carron, J. M., Clark, R. D., Kluge, A. F. et al.: J. Med. Chem., 1981; 24, 1320.
  35. Baldwin, J. J., McClure, D. E., Gross, D. M.: J. Med. Chem., 1982; 25, 931. Go to original source... Go to PubMed...




Czech and Slovak Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.